Abstract
Dry powder inhalers offer many advantages in the management, prevention and treatment of various respiratory diseases and also with tumors associated with lungs. The present study investigated the feasibility of formulating Cisplatin loaded Gelatin nanoparticles as colloidal drug carriers and converting them into dry powders by coating with inhalable lactose by freeze drying. The average particle size of Cisplatin gelatin nanoparticles was found to be 314 nm by two step desolvation technique. The mean geometric size of the carrier particles was found to be 2.8 ± 0.3 µm. Freeze dried nanoparticles were further mixed with various grades of inhalable lactoses and filled into hard gelatin capsules. In-vitro drug deposition pattern and physicochemical characteristics of nanoparticulate and conventional dry powder inhaler capsule formulation were compared. Results indicated that the developed gelatin nanoparticulate dry powder inhaler capsules possessed higher respirable fraction of 31.4% as compared to conventional dry powder capsule formulation.
The present investigation demonstrates that there is a possibility of delivering the nanoparticles to the lungs by incorporating them into carrier particles by simple adsorption. This provides an innovative path for delivering cytotoxic drugs to the lungs by inhalation.
Keywords: Cisplatin, desolvation, dry powder inhalers, lung cancer, nanoparticles.
Current Nanoscience
Title:Development of Cisplatin Nanoparticles as Dry Powder Inhalers for Lung Cancer
Volume: 9 Issue: 4
Author(s): Amrita K. Rao, Shruti Shrikhande and Amrita Bajaj
Affiliation:
Keywords: Cisplatin, desolvation, dry powder inhalers, lung cancer, nanoparticles.
Abstract: Dry powder inhalers offer many advantages in the management, prevention and treatment of various respiratory diseases and also with tumors associated with lungs. The present study investigated the feasibility of formulating Cisplatin loaded Gelatin nanoparticles as colloidal drug carriers and converting them into dry powders by coating with inhalable lactose by freeze drying. The average particle size of Cisplatin gelatin nanoparticles was found to be 314 nm by two step desolvation technique. The mean geometric size of the carrier particles was found to be 2.8 ± 0.3 µm. Freeze dried nanoparticles were further mixed with various grades of inhalable lactoses and filled into hard gelatin capsules. In-vitro drug deposition pattern and physicochemical characteristics of nanoparticulate and conventional dry powder inhaler capsule formulation were compared. Results indicated that the developed gelatin nanoparticulate dry powder inhaler capsules possessed higher respirable fraction of 31.4% as compared to conventional dry powder capsule formulation.
The present investigation demonstrates that there is a possibility of delivering the nanoparticles to the lungs by incorporating them into carrier particles by simple adsorption. This provides an innovative path for delivering cytotoxic drugs to the lungs by inhalation.
Export Options
About this article
Cite this article as:
Rao K. Amrita, Shrikhande Shruti and Bajaj Amrita, Development of Cisplatin Nanoparticles as Dry Powder Inhalers for Lung Cancer, Current Nanoscience 2013; 9 (4) . https://dx.doi.org/10.2174/1573413711309040005
DOI https://dx.doi.org/10.2174/1573413711309040005 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Advances in Treatment of Lung Cancer: Nanoparticle-based Drug and siRNA Delivery Systems
Current Drug Delivery Malignant Mesothelioma Resistance to Apoptosis: Recent Discoveries and their Implication for Effective Therapeutic Strategies
Current Medicinal Chemistry Extending Arms of Insulin Resistance from Diabetes to Alzheimer’s Disease: Identification of Potential Therapeutic Targets
CNS & Neurological Disorders - Drug Targets Lessons in Medical Record Abstraction from the Prostate, Lung, Colorectal, and Ovarian (PLCO) National Screening Trial
Reviews on Recent Clinical Trials Toxicogenomics to Improve Comprehension of the Mechanisms Underlying Responses of In Vitro and In Vivo Systems to Nanomaterials: A Review
Current Genomics Cyclooxygenase-2 Inhibitors: A Painful Lesson
Cardiovascular & Hematological Disorders-Drug Targets The Characteristics, Functions and Inhibitors of Three Aminopeptidases Belonging to the M1 Family
Current Protein & Peptide Science Histone Deacetylase Inhibitors In Inflammatory Disease
Current Topics in Medicinal Chemistry Drug Targets to Pro-Angiogenetic Factors with Special Reference to Primary Peritoneal Mesothelioma
Endocrine, Metabolic & Immune Disorders - Drug Targets Scheduling of Taxanes: A Review
Current Clinical Pharmacology Glucocorticoids and Vascular Reactivity
Current Vascular Pharmacology Fcγ Receptor 1 (CD64), a Target Beyond Cancer
Current Pharmaceutical Design Angiotensin Peptides and Lung Cancer
Current Cancer Drug Targets Inhibition of Protein Kinase c-Src as a Therapeutic Approach for Cancer and Bone Metastases
Anti-Cancer Agents in Medicinal Chemistry Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
Current Vascular Pharmacology Somatostatin, Somatostatin Analogs and Somatostatin Receptor Dynamics in the Biology of Cancer Progression
Current Molecular Medicine Anticancer Potential of Aguerin B, a Sesquiterpene Lactone Isolated from <i>Centaurea behen</i> in Metastatic Breast Cancer Cells
Recent Patents on Anti-Cancer Drug Discovery Polymeric Nanomaterials as Nanomembrane Entities for Biomolecule and Drug Delivery
Current Pharmaceutical Design The mTOR/4E-BP1/eIF4E Signalling Pathway as a Source of Cancer Drug Targets
Current Medicinal Chemistry Regression of Oxidative Stress by Targeting eNOS and Nrf2/ARE Signaling: A Guided Drug Target for Cardiovascular Diseases
Current Topics in Medicinal Chemistry